Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Share-based Compensation (2017 - 2025)

Catheter Precision (VTAK) has disclosed Share-based Compensation for 8 consecutive years, with $70000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Share-based Compensation rose 311.76% to $70000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $277000.0, a 793.55% increase, with the full-year FY2024 number at $54000.0, down 95.56% from a year prior.
  • Share-based Compensation was $70000.0 for Q3 2025 at Catheter Precision, down from $98000.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $1.4 million in Q1 2023 to a low of -$174000.0 in Q2 2023.
  • A 5-year average of $221947.4 and a median of $82000.0 in 2022 define the central range for Share-based Compensation.
  • Peak YoY movement for Share-based Compensation: tumbled 234.88% in 2023, then skyrocketed 1416.67% in 2025.
  • Catheter Precision's Share-based Compensation stood at $270000.0 in 2021, then crashed by 69.63% to $82000.0 in 2022, then tumbled by 106.1% to -$5000.0 in 2023, then surged by 460.0% to $18000.0 in 2024, then skyrocketed by 288.89% to $70000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Share-based Compensation are $70000.0 (Q3 2025), $98000.0 (Q2 2025), and $91000.0 (Q1 2025).